(RTTNews) - AstraZeneca Plc. (AZN.ST, ZEG.DE, AZN.L, AZN) announced a major investment of $50 billion in the United States by ...

AstraZeneca (NASDAQ: AZN) has unveiled plans to invest $50 billion in U.S. manufacturing and RD infrastructure by 2030, ...

AstraZeneca announces $50B US investment by 2030, creating thousands of jobs and building its largest drug manufacturing facility in Virginia.

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...

The U.K. biopharmaceutical giant’s plans include a proposal for a new drug substance manufacturing center focused on ...

Astegolimab from Roche's Genentech fails phase 3 COPD trial, reflecting challenges in monoclonal antibody treatment for the ...

AstraZeneca (LSE:AZN) recently announced positive developments regarding TAGRISSO®'s survival benefits in treating non-small ...

AstraZeneca shares have dropped substantially from their record-breaking heyday in September, but is this the ideal time for me to buy more of them? The post Is it worth me buying more AstraZeneca ...

DAZN have been forced to issue advice after the streaming platform was hammered by complaints as the Oleksandr Usyk vs Daniel Dubois fight coverage was littered with problems ...

AstraZeneca PLC (NASDAQ:AZN) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. AstraZeneca PLC (NASDAQ:AZN ...

The US pharmaceutical industry has undergone notable shifts in recent years, influenced by factors such as the COVID-19 ...

AstraZeneca (LSE:AZN) recently announced that its investigational antibody, anselamimab, did not achieve statistical ...